Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
01 2Biophore India Pharmaceuticals Pvt Ltd
02 1ANDA Repository
03 1Amphastar Pharmaceuticals
04 1Annora Pharma
05 13Bayer AG
06 15Bracco
07 6GE Healthcare Inc
08 2Jodas Expoim Pvt. Ltd
09 4Mallinckrodt Pharmaceuticals
10 2ORIFARM GROUP AS
11 1Xian Libang Pharmaceutical Co.,Ltd
01 1Diatrizoico Acid 370Mg Iodine/Ml 100Ml Oral Or Rectal Administration
02 22INJECTABLE;INJECTION
03 5Injection
04 1LIQ
05 1Melange/rectal fluid, resolution
06 3ORAL SOLUTION / REKTALLÖSNING
07 1SOLUTION
08 1SOLUTION;INTRAUTERINE
09 5SOLUTION;ORAL, RECTAL
10 3SOLUTION;URETERAL
11 3SOLUTION;URETHRAL
12 2Solution
01 28DISCN
02 1Ethical
03 2Generic
04 1Originator
05 6RX
06 10Blank
01 1ANGIOVIST 282
02 1ANGIOVIST 292
03 1ANGIOVIST 370
04 1CARDIOGRAFIN
05 1CYSTOGRAFIN
06 1CYSTOGRAFIN DILUTE
07 1DIATRIZOATE MEGLUMINE
08 2DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
09 1DIATRIZOATE-60
10 2GASTROGRAFIN
11 1GASTROVIST
12 8Gastrografin
13 2HYPAQUE
14 1HYPAQUE-76
15 1HYPAQUE-CYSTO
16 1HYPAQUE-M,75%
17 1HYPAQUE-M,90%
18 1MD-60
19 1MD-76
20 1MD-76R
21 1MD-GASTROVIEW
22 1RENO-30
23 1RENO-60
24 1RENO-DIP
25 1RENOCAL-76
26 1RENOGRAFIN-60
27 1RENOGRAFIN-76
28 1RENOVIST
29 1RENOVIST II
30 1SINOGRAFIN
31 1UROVIST CYSTO
32 1UROVIST CYSTO PEDIATRIC
33 1UROVIST MEGLUMINE DIU/CT
34 5Blank
01 1Canada
02 1China
03 4India
04 1Italy
05 1Norway
06 1South Africa
07 3Sweden
08 2Switzerland
09 34USA
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 60%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Diatrizoate Sodium; Diatrizoate Meglumine
Brand Name :
Dosage Form : Injection
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOGRAFIN-76
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOGRAFIN-60
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 52%;8%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RENO-DIP
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 30%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RENO-60
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 60%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DIATRIZOATE MEGLUMINE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 76%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CYSTOGRAFIN
Dosage Form : SOLUTION;URETHRAL
Dosage Strength : 30%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOVIST II
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 28.5%;29.1%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOVIST
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 34.3%;35%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RENO-30
Dosage Form : SOLUTION;URETERAL
Dosage Strength : 30%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CYSTOGRAFIN DILUTE
Dosage Form : SOLUTION;URETHRAL
Dosage Strength : 18%
Packaging :
Approval Date : 1982-11-09
Application Number : 10040
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : GASTROGRAFIN
Dosage Form : SOLUTION;ORAL, RECTAL
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 11245
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; IODIPAMIDE MEGLUMINE
Brand Name : SINOGRAFIN
Dosage Form : SOLUTION;INTRAUTERINE
Dosage Strength : 52.7%;26.8%
Packaging :
Approval Date : 1982-01-01
Application Number : 11324
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CARDIOGRAFIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 85%
Packaging :
Approval Date : 1982-01-01
Application Number : 11620
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : HYPAQUE-M,90%
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 60%;30%
Packaging :
Approval Date : 1982-01-01
Application Number : 10220
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : HYPAQUE-M,75%
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50%;25%
Packaging :
Approval Date : 1982-01-01
Application Number : 10220
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 60%
Packaging :
Approval Date : 1982-01-01
Application Number : 16403
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 30%
Packaging :
Approval Date : 1982-01-01
Application Number : 16403
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE-CYSTO
Dosage Form : SOLUTION;URETHRAL
Dosage Strength : 30%
Packaging :
Approval Date : 1982-01-01
Application Number : 16403
Regulatory Info : DISCN
Registration Country : USA
LOOKING FOR A SUPPLIER?
